Expanding PRIME: Ensuring Faster Access to Orphan Medicinal Products in the EU
The importance of achieving a 180-day assessment timeline for medicines
Vitality of the EU Biotech Sector Depends on a Positive EU Policy Direction
Trans-Atlantic Perspectives on the Future of Pharma
From the EUCOPE Blog archives
The European Health Data Space (EHDS): Ensuring the digital transformation of healthcare in Europe
July 26, 2023
The Path to Innovation in Rare Diseases comes through Partnerships – A reflection on the EU Pharmaceutical Package
May 3, 2023
Rare Disease Day 2023: A Shared Vision for the EU Rare Disease Ecosystem
February 22, 2023
World Cancer Day 2023: Fostering the EU Advanced Diagnostics Ecosystem to tackle the Cancer Burden
February 2, 2023
Launch Conditionality: What’s at stake?
December 19, 2022
To the archives
